Celgene (CELG), Acceleron (XLRN) Announce Receipt FDA Fast-Track Designation for Luspatercept in Two Indication
Tweet Send to a Friend
Celgene (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that the United States Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
